Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Medicenna Therapeutics Corp T.MDNA

Alternate Symbol(s):  MDNAF

Healthcare Biotechnology
Medicenna Therapeutics Corp. is a Canada-based clinical-stage immunotherapy company. The Company's principal business activity is the development and commercialization of interleukin-2 (IL-2), interleukin-4 (IL-4) and interleukin-13 (IL-13) Superkines and Empowered Superkines for the treatment of cancer, inflammation and immune-mediated diseases. Its long-acting IL-2 Superkine, MDNA11, is an IL... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:MDNA)

Medicenna Reports Second Quarter Fiscal 2025 Financial Results and Corporate Update

GlobeNewswire 6 days ago

Medicenna Announces Upcoming Presentations at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO) and the 2024 San Antonio Breast Cancer Symposium (SABCS)

GlobeNewswire 8 days ago

Medicenna Announces Positive Single-Agent Activity of MDNA11 from Dose Expansion Cohort and Encouraging Safety Profile in Combination with KEYTRUDA® (pembrolizumab) at the 39th Annual Meeting of SITC

GlobeNewswire 10 days ago

Medicenna Presents Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

GlobeNewswire 13 days ago

OTC Markets Group Welcomes Medicenna Therapeutics Corp. to OTCQX

GlobeNewswire October 15, 2024

Medicenna to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

GlobeNewswire October 4, 2024

Medicenna Announces Results of Annual Meeting of Shareholders

GlobeNewswire September 26, 2024

Medicenna Presents Preclinical Results from its IL-2 Super-Antagonist and Anti-PD1-IL-2 BiSKIT Programs at The Promise of Interleukin-2 Therapy Conference

GlobeNewswire September 9, 2024

Medicenna to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire September 5, 2024
View More News ››

Opinion & Analysis (TSX:MDNA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:MDNA)

SITC NEWS!!!

Mono therapy ORR of 25% (FDA worthy) And  Combo therapy   3 SD and one PR already Yipeee MERCK must be sniffing...
ENEMENEMYNEMO - 12 days ago

RE:Medicenna Reports First Quarter Fiscal 2025 Financial Result

Nice addition to the board today!
windymayor1 - August 15, 2024

Medicenna Reports First Quarter Fiscal 2025 Financial Result

BREAKING NEWS: $MDNAF Medicenna Reports First Quarter Fiscal 2025 Financial Results and Announces First Complete Responder with MDNA11...
whytestocks - August 1, 2024

RE:RE:RE:RE:Today's news

Nice recovery above $2.00!
windymayor1 - June 26, 2024

RE:RE:RE:Today's news

Not today .
Galaxym31 - June 17, 2024

RE:RE:Today's news

#2 Top % gainer today on TSX
windymayor1 - June 11, 2024
View more Bullboard ››

Africa Oil Corp.

Africa Oil Corp.

Africa Oil Corp. is a Canadian oil and gas company with producing and development assets in deepwater Nigeria, an interest in ...
View More »